世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039163

埋め込み型ドラッグデリバリーデバイス市場:規模、シェア、動向分析レポート、およびセグメント予測、2024〜2030

Grand View Research Inc.

Implantable Drug Delivery Devices Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2024- 2030

発刊日 2024/08

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000039163

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

埋め込み型ドラッグデリバリーデバイスの市場規模、シェア、動向分析レポート:製品別、タイプ別 (生分解性、非生分解性)、技術別、用途別、地域別、セグメント別予測、2024-2030

市場規模と動向

世界の埋め込み型ドラッグデリバリーデバイスの市場規模は、2023年に272億ドルと評価され、2024年から2030年にかけて8.2%のCAGRで成長すると予測されます。感染症や非感染性疾患などの慢性疾患の発生率の増加が市場の成長を促進する主な要因です。WHOによると、がんによる死亡の増加により、医療現場では埋め込み型薬物送達デバイスなどの高度な治療オプションを採用する緊急性が高まっています。

レポート詳細

目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market
1.2. Segmentation and Scope
1.3. Market Definitions
1.4. Research Methodology
1.4.1. Information Procurement
1.4.2. Information or Data Analysis
1.4.3. Market Formulation & Data Visualization
1.4.4. Data Validation & Publishing
1.5. Research Scope and Assumptions
1.5.1. List of Data Sources

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Implantable Drug Delivery Devices Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Implantable Drug Delivery Devices Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape

Chapter 4. Implantable Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Implantable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Contraceptive Implants
4.3.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Spinal Implants
4.4.1. Spinal Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Brachytherapy Seeds
4.5.1. Brachytherapy Seeds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Drug Eluting Stents
4.6.1. Drug Eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Bioabsorbable Stents
4.7.1. Bioabsorbable Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Intraocular Implants
4.8.1. Intraocular Implants Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.9. Infusion Pumps
4.9.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.10. Others
4.10.1. Others Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 5. Implantable Drug Delivery Devices Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Implantable Drug Delivery Devices Market: Type Movement Analysis, 2023 & 2030 (USD Million)
5.3. Biodegradable
5.3.1. Biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Non-biodegradable
5.4.1. Non-biodegradable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Implantable Drug Delivery Devices Market: Technology Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Implantable Drug Delivery Devices Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
6.3. Diffusion
6.3.1. Diffusion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Osmotic
6.4.1. Osmotic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Magnetic
6.5.1. Magnetic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Implantable Drug Delivery Devices Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Implantable Drug Delivery Devices Market: Application Movement Analysis, 2023 & 2030 (USD Million)
7.3. Contraception
7.3.1. Contraception Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Ophthalmology
7.4.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Cardiovascular
7.5.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Diabetes
7.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Oncology
7.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Autoimmune Diseases
7.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. Others
7.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Implantable Drug Delivery Devices Market: Regional Estimates & Trend Analysis
8.1. Implantable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. U.K.
8.3.2.1. U.K. Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. China Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Japan Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. South Korea
8.4.5.1. South Korea Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. Australia
8.4.6.1. Australia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. Saudi Arabia
8.6.2.1. Saudi Arabia Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. UAE
8.6.3.1. UAE Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. South Africa
8.6.4.1. South Africa Implantable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Medtronic
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Boston Scientific Corporation
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Allergan
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Merck & Co., Inc.
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bausch and Lomb Incorporated
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Bayer AG
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Abbott
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Teleflex Incorporated
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Varian Medical Systems, Inc.
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives

この商品のレポートナンバー

0000039163

TOP